Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismael Al-Ramahi

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Science Translational Medicine|December 26, 2014
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's diseaseXiao-Hong Lu, Virginia B Mattis, Nan Wang, et al.
Nature|May 31, 2013
RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1Jeehye Park, Ismael Al-Ramahi, Qiumin Tan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2018
A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation ApproachMaxime W C Rousseaux, Gabriel E Vázquez-Vélez, Ismael Al-Ramahi, et al.
Cell Reports|March 8, 2025
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's diseaseThomas P Spargo, Chloe F Sands, Isabella R Juan, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Science Translational Medicine|December 26, 2014
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's diseaseXiao-Hong Lu, Virginia B Mattis, Nan Wang, et al.
Nature|May 31, 2013
RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1Jeehye Park, Ismael Al-Ramahi, Qiumin Tan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2018
A Druggable Genome Screen Identifies Modifiers of α-Synuclein Levels via a Tiered Cross-Species Validation ApproachMaxime W C Rousseaux, Gabriel E Vázquez-Vélez, Ismael Al-Ramahi, et al.
Cell Reports|March 8, 2025
Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson's diseaseThomas P Spargo, Chloe F Sands, Isabella R Juan, et al.
Pageof 6